03307nam 2200409 450 991064722420332120230324055403.03-0365-5764-4(CKB)5680000000300105(NjHacI)995680000000300105(EXLCZ)99568000000030010520230324d2023 uy 0engur|||||||||||txtrdacontentcrdamediacrrdacarrierEndocrine and Neuroendocrine Cancers /Alfredo Berruti, Vito Amoroso, Nicola Fazio, editors[Place of publication not identified] :MDPI - Multidisciplinary Digital Publishing Institute,2023.1 online resource (198 pages)3-0365-5763-6 Preface to "Endocrine and Neuroendocrine Cancers" vii -- Endocrine and Neuroendocrine Tumors: A Special Issue 1 -- Addressing the Role of Angiogenesis in Patients with Advanced Pancreatic Neuroendocrine Tumors Treated with Everolimus: A Biological Prospective Analysis of Soluble Biomarkers and Clinical Outcomes 5 -- Clinical Management of Neuroendocrine Neoplasms in Clinical Practice: A Formal Consensus Exercise 19 -- Establishment of Novel Neuroendocrine Carcinoma Patient-Derived Xenograft Models for Receptor Peptide-Targeted Therapy 39 -- Molecular Profiling o f Well-Differentiated N euroendocrine T umours: T he R ole o f c tDNA in Real-World Practice 53 -- Predictive and Prognostic Role of Pre-Therapy and Interim 68Ga-DOTATOC PET/CT Parameters in Metastatic Advanced Neuroendocrine Tumor Patients Treated with PRRT 63 -- Active Surveillance in RET Gene Carriers Belonging to Families with Multiple Endocrine Neoplasia 75 -- Epithelial and Mesenchymal Markers in Adrenocortical Tissues: How Mesenchymal Are Adrenocortical Tissues? 89 -- Anaplastic Thyroid Carcinoma: An Update 103 -- Carcinoid Crisis: A Misunderstood and Unrecognized Oncological Emergency 129 -- Endocrine and Neuroendocrine Tumors Special Issue-Checkpoint Inhibitors for Adrenocortical Carcinoma and Metastatic Pheochromocytoma and Paraganglioma: Do They Work? 143 -- Cardiovascular Toxicities Secondary to Biotherapy and Molecular Targeted Therapies in Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials 159 -- Neuroendocrine Carcinomas with Atypical Proliferation Index and Clinical Behavior: A -- Systematic Review 177.Endocrine and neuroendocrine tumors originate from endocrine cells but are heterogeneous in terms of clinical presentation, disease outcome, and treatments available. This Special Issue addresses specific aspects of pre-clinical, clinical, and translational research and clinical management of these diseases with the aim of providing novel insights, addressing current unmet needs, and discussing future treatment perspectives.Neuroendocrine tumorsNeuroendocrinologyNeuroendocrine tumors.Neuroendocrinology.616.9944Fazio NicolaAmoroso VitoBerruti AlfredoNjHacINjHaclBOOK9910647224203321Endocrine and Neuroendocrine Cancers3018132UNINA